• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket

    4/4/23 8:04:58 AM ET
    $ADXN
    $AMC
    $BFLY
    $CDAK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Movies/Entertainment
    Consumer Discretionary
    Get the next $ADXN alert in real time by email

    Gainers

    • AMC Entertainment Hldg Pref Equity Units (NYSE:APE) gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with converting its preferred stock into common shares.
    • Butterfly Network, Inc. (NASDAQ:BFLY) jumped 26.2% to $2.36 in pre-market trading after the company received 510(k) clearance for AI-Enable Auto B-Line Counter.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) gained 15.7% to $1.15 in pre-market trading. Addex published dipraglurant data showing in vivo efficacy on motor and non-motor symptoms of Parkinson's disease.
    • Meta Materials Inc. (NASDAQ:MMAT) shares climbed 13.2% to $0.5565 in pre-market trading after jumping 20% on Monday. Meta Materials recently signed a joint development agreement for NPORE battery separator materials with a confidential global Top 10 battery OEM.
    • Clever Leaves Holdings Inc (NASDAQ:CLVR) climbed 12.3% to $0.40 in pre-market trading. The company recently posted upbeat Q4 results.
    • Steakholder Foods Ltd (NASDAQ:STKH) gained 11% to $0.76 in pre-market trading after declining over 3% on Monday.
    • Lipocine Inc (NASDAQ:LPCN) gained 10.4% to $0.35 in pre-market trading. Lipocine said first participant has been dosed in pilot clinical bridge study of LPCN 1154 and approved injectable Brexanolone.
    • Wearable Devices Ltd (NASDAQ:WLDS) surged 9.6% to $0.51 in pre-market trading after dropping more than 10% on Monday. Wearable Devices recently reported 2022 financial results.
    • Comera Life Sciences Holdings Inc (NASDAQ:CMRA) climbed 9% to $0.97 in pre-market trading. Comera Life Sciences announced notice of allowance of US patent application for expansion of core viscosity reduction claims for excipients in SQore platform.
    • PLx Pharma Inc (NASDAQ:PLXP) gained 8.8% to $0.13 in pre-market trading after dropping around 4% on Monday.

    Losers

    • Oncternal Therapeutics, Inc. (NASDAQ:ONCT) fell 57.1% to $0.3390 in pre-market trading after the company disclosed strategic reprioritization and capital preservation. The Zilovertamab Phase 3 study ZILO-301 and Phase 1/2 study CIRM-0001 will be closed based on dynamically changing therapeutic landscape.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) fell 25% to $3.83 in pre-market trading. AMC Entertainment agreed to settle litigation and move forward with converting its preferred stock into common shares.
    • Remark Holdings Inc (NASDAQ:MARK) shares dropped 16.2% to $1.24 in pre-market trading after the company filed non-timely 10-K with the SEC. The company said it expects revenue for the year ended Dec. 31, 2022 to be significantly less year over year.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) fell 14.2% to $0.1110 in pre-market trading after dipping over 25% on Monday. Codiak BioSciences recently voluntarily filed for protection under Chapter 11 bankruptcy.
    • ReTo Eco-Solutions Inc (NASDAQ:RETO) fell 11% to $0.32 in pre-market trading after dropping around 8% on Monday. ReTo Eco-Solutions subsidiary recently received overseas order for fully automated block production lines.
    • Harbor Custom Development Inc (NASDAQ:HCDI) fell 8.7% to $5.47 in pre-market after jumping 38% on Monday. Harbor Custom Development recently reported worse-than-expected Q4 sales results.
    • T Stamp Inc (NASDAQ:IDAI) fell 8.3% to $2.75 in pre-market trading. T Stamp filed for mixed-securities shelf offering of up to $50 million.
    • Terran Orbital Corporation (NYSE:LLAP) shares fell 7.5% to $1.72 in pre-market trading.
    • Kazia Therapeutics Ltd (NASDAQ:KZIA) fell 6.8% to $0.96 in pre-market trading.
    • Alaunos Therapeutics Inc (NASDAQ:TCRT) shares fell 5.7% to $0.59 in pre-market trading.

    Now Read This: Top 4 Materials Stocks That Set To Fly In April

    Get the next $ADXN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADXN
    $AMC
    $BFLY
    $CDAK

    CompanyDatePrice TargetRatingAnalyst
    Butterfly Network Inc.
    $BFLY
    8/1/2025Outperform → Perform
    Oppenheimer
    AMC Entertainment Holdings Inc.
    $AMC
    7/11/2025$4.00Neutral → Outperform
    Wedbush
    Butterfly Network Inc.
    $BFLY
    7/1/2025$3.00Buy
    Craig Hallum
    AMC Entertainment Holdings Inc.
    $AMC
    5/16/2025$3.00Neutral
    B. Riley Securities
    Butterfly Network Inc.
    $BFLY
    3/17/2025Outperform
    William Blair
    Kazia Therapeutics Limited
    $KZIA
    2/6/2025$3.00Buy
    Maxim Group
    AMC Entertainment Holdings Inc.
    $AMC
    2/4/2025$4.00 → $3.25Sell → Neutral
    ROTH MKM
    Butterfly Network Inc.
    $BFLY
    9/10/2024$3.00Buy
    Lake Street
    More analyst ratings

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Phanstiel S. Louise bought $571,160 worth of shares (185,261 units at $3.08) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/17/25 4:10:13 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $64,471 worth of shares (21,370 units at $3.02) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/15/25 6:20:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    Director Robbins Larry bought $4,652,773 worth of shares (1,558,541 units at $2.99) (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    12/5/25 5:40:49 PM ET
    $BFLY
    Medical Electronics
    Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Butterfly Network downgraded by Oppenheimer

    Oppenheimer downgraded Butterfly Network from Outperform to Perform

    8/1/25 12:44:19 PM ET
    $BFLY
    Medical Electronics
    Health Care

    AMC Entertainment upgraded by Wedbush with a new price target

    Wedbush upgraded AMC Entertainment from Neutral to Outperform and set a new price target of $4.00

    7/11/25 7:55:26 AM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    Craig Hallum initiated coverage on Butterfly Network with a new price target

    Craig Hallum initiated coverage of Butterfly Network with a rating of Buy and set a new price target of $3.00

    7/1/25 8:24:04 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Patel Mahesh V.

    4 - Lipocine Inc. (0001535955) (Issuer)

    4/2/26 5:05:58 PM ET
    $LPCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Cain David

    3 - KAZIA THERAPEUTICS LTD (0001075880) (Issuer)

    4/1/26 9:20:30 AM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Mcclintock William

    4 - T Stamp Inc (0001718939) (Issuer)

    4/1/26 9:03:02 AM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    $ADXN
    $AMC
    $BFLY
    $CDAK
    SEC Filings

    View All

    SEC Form 8-K filed by Lipocine Inc.

    8-K - Lipocine Inc. (0001535955) (Filer)

    4/2/26 9:40:13 AM ET
    $LPCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lipocine Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Lipocine Inc. (0001535955) (Filer)

    4/2/26 9:35:13 AM ET
    $LPCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AMC Entertainment Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - AMC ENTERTAINMENT HOLDINGS, INC. (0001411579) (Filer)

    4/1/26 4:55:42 PM ET
    $AMC
    Movies/Entertainment
    Consumer Discretionary

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Trust Stamp provides a comprehensive business briefing for Q1 of 2026 reporting strong progress across multiple business geographies and verticals

    Atlanta, GA, March 31, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (NASDAQ:IDAI) provided a business update for Q1 of 2026. Gareth N. Genner, Chief Executive Officer of the Company commented, "In 2025 we reduced and optimized expenditure, focusing our resources on projects that we believed to be best positioned to generate meaningful revenue in 2026 and 2027. Based on that strategy, we have seen significant revenue-focused progress on multiple fronts in Q1: In January we received a Purchase Order for the use of our Irreversibly Transformed Identity Token ("IT2") from a telecommunications company situated across a dozen African and Middle Eastern markets and serving hundreds of millions of subsc

    3/31/26 4:10:00 PM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    Trust Stamp filed its 10-K for the year ending December 31, 2025 reflecting strong growth in customer enrollments and user completions with a 33.6% year-on-year decrease in Comprehensive Operating Loss

    Atlanta, GA, March 31, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (NASDAQ:IDAI) announced that: It filed its 10-K report for the year ended December 31, 2025 after the Nasdaq market closed on March 31, 2026.Net recognised revenue for the year ended December 31, 2025 was $3.14 million, an increase of 2% from $3.08 million for the corresponding period in 2024. The increase was primarily attributable to the S&P 500 bank customer contract amendment in 2025. The amendment extended the term of the existing agreement until May 31, 2031 (subject to a right for the customer to cancel for convenience on 6 months notice), with a minimum gross revenue exceeding $12.7 million over the term of the contract.

    3/31/26 4:10:00 PM ET
    $IDAI
    Computer Software: Prepackaged Software
    Technology

    Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health

    The new AI-powered tool determines how far along a pregnancy is in minutes—providing critical information to guide timely care and help reduce maternal and fetal mortality worldwide. Butterfly Network, Inc. ("Butterfly," "the Company") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for a fully automated Gestational Age (GA) Tool integrated into its handheld ultrasound solution. This marks the first FDA-cleared blind-sweep ultrasound AI tool for estimating gestational age. This press release features multimedia. View the full release

    3/30/26 8:00:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TESTOSTERONE UNDECANOATE issued to LIPOCINE INC

    Submission status for LIPOCINE INC's drug TESTOSTERONE UNDECANOATE (ORIG-1) with active ingredient TESTOSTERONE UNDECANOATE has changed to 'Approval' on 03/28/2022. Application Category: NDA, Application Number: 208088, Application Classification: Type 3 - New Dosage Form

    3/29/22 4:34:43 AM ET
    $LPCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for TESTOSTERONE UNDECANOATE

    Submission status for LIPOCINE INC's drug TESTOSTERONE UNDECANOATE (ORIG-1) with active ingredient TESTOSTERONE UNDECANOATE has changed to 'Tentative Approval' on 12/08/2020. Application Category: NDA, Application Number: 208088, Application Classification: Type 3 - New Dosage Form

    12/20/20 4:30:41 PM ET
    $LPCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:32:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:31:02 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by ReTo Eco-Solutions Inc.

    SC 13G/A - ReTo Eco-Solutions, Inc. (0001687277) (Subject)

    12/3/24 8:30:28 AM ET
    $RETO
    Industrial Machinery/Components
    Industrials

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Financials

    Live finance-specific insights

    View All

    Wearable Devices Reports Full Year 2025 Financial Results, Highlights Revenue Growth, $24.4 Million Raised in 2025 and $18.4 Million Cash Position

    YOKNE'AM ILLIT, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced its financial results for the year ended December 31, 2025. The Company reported revenue growth for the year, driven in part by a 28.5% increase in sales of its Mudra Link and Mudra Band products, reflecting growing adoption of its gesture-control technology and continued expansion of its business-to-client ("B2C") segment. Management Commentary "We are pleased to conclude 2025 with steady momentum in our B2C sector, drive

    3/12/26 9:00:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    Lipocine Announces Financial Results for the Full Year Ended December 31, 2025

    SALT LAKE CITY, March 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ:LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the full year ended December 31, 2025 and provided a corporate update. "We believe 2025 was a pivotal year for Lipocine as we continue to advance our pipeline and expand our market presence. The progress we've made, especially with our postpartum depression therapeutic, LPCN 1154, demonstrates the strength of our science and our team's c

    3/10/26 8:00:00 AM ET
    $LPCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2025

    Fourth quarter operating income increases year-over-year and fourth quarter adjusted OIBDA exceeds guidance Fourth quarter revenue growth of 8% outpaced attendance as NCM attracted greater advertiser demand National CineMedia, Inc. (NASDAQ:NCMI) (the "Company" or "NCM"), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., announced today its consolidated results for the fiscal fourth quarter and year ended January 1, 2026. "NCM expanded fourth quarter revenue by 8% year-over-year, demonstrating the returns from our continued investment in our platform over the course of the year," said Tom Lesinski, Chief Execu

    2/26/26 4:05:00 PM ET
    $AMC
    $CNK
    $NCMI
    Movies/Entertainment
    Consumer Discretionary
    Advertising

    $ADXN
    $AMC
    $BFLY
    $CDAK
    Leadership Updates

    Live Leadership Updates

    View All

    Wearable Devices Strengthens AI Advisory Board with Former Google and Qualcomm Executives to Accelerate ai6 Labs' Vision

    Yokneam Illit, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (NASDAQ:WLDS, WLDSW)) ("Wearable Devices" or the "Company"), a technology growth company specializing in artificial intelligence ("AI")-powered touchless sensing wearables, today announced a significant expansion of its AI expert advisory board. This strategic enhancement strengthens the Company's commitment to advancing neural AI innovation through ai6 Labs. The recently launched ai6 Labs is focused on advancing the Company's revolutionary neural AI technology powered by non-invasive electromyography (EMG) technology and the Mudra platform, supporting a closed-loop ecosystem designed to seamlessly connect hu

    3/16/26 8:45:00 AM ET
    $WLDS
    Computer Communications Equipment
    Telecommunications

    Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

    Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic

    3/10/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    LAIKA Partners With Fathom Entertainment for Domestic Distribution and FilmNation Entertainment for International Sales on Wildwood

    Confirms October 23, 2026 U.S. Release Date LAIKA, the studio behind Coraline and ParaNorman, announced today that it has partnered with Fathom Entertainment for U.S. theatrical distribution and FilmNation Entertainment for international sales on its upcoming stop-motion feature film Wildwood. The film will open in theaters nationwide on October 23, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120938376/en/LAIKA Names Fathom Entertainment as US Distributor and FilmNation Entertainment for International Sales for "Wildwood" coming October 23, 2026 The announcement reflects a new phase for LAIKA, as the studio expands

    1/20/26 11:15:00 AM ET
    $AMC
    $CNK
    Movies/Entertainment
    Consumer Discretionary